In addition, this therapeutic combination also notably diminished tumor growth in pancreatic CSC xenograft models, largely via the suppression of EMT-associated proteins, such as Zeb-1, Twist2, and vimentin [114]. The gene discussed is VIM; the disease is neoplasm.